Clinical course and CSF amyloid β protein precursor having the site of application of the protease inhibitor (APPI) levels in patients with dementia of the Alzheimer type [1]
K. Urakami, K. Takahashi, A. Okada, T. Oshima, Y. Adachi, S. Nakamura, N. Kitaguchi, Y. Tokushima, S. Yamamoto, S. Tanaka
研究成果: ジャーナルへの寄稿 › Letter › 査読
5
被引用数
(Scopus)